Probiotics in Intestinal Mucosal Healing: A New Therapy or an Old Friend?
- PMID: 34832962
- PMCID: PMC8622522
- DOI: 10.3390/ph14111181
Probiotics in Intestinal Mucosal Healing: A New Therapy or an Old Friend?
Abstract
Inflammatory bowel disease (IBD), Crohn's disease, and ulcerative colitis are characterized by chronic and relapsing inflammation, while their pathogenesis remains mostly unelucidated. Gut commensal microbiota seem to be one of the various implicated factors, as several studies have shown a significant decrease in the microbiome diversity of patients with IBD. Although the question of whether microbiota dysbiosis is a causal factor or the result of chronic inflammation remains unanswered, one fact is clear; active inflammation in IBD results in the disruption of the mucus layer structure, barrier function, and also, colonization sites. Recently, many studies on IBD have been focusing on the interplay between mucosal and luminal microbiota, underlining their possible beneficial effect on mucosal healing. Regarding this notion, it has now been shown that specific probiotic strains, when administrated, lead to significantly decreased inflammation, amelioration of colitis, and improved mucosal healing. Probiotics are live microorganisms exerting beneficial effects on the host's health when administered in adequate quantity. The aim of this review was to present and discuss the current findings on the role of gut microbiota and their metabolites in intestinal wound healing and the effects of probiotics on intestinal mucosal wound closure.
Keywords: gut microbiota; inflammatory bowel disease; intestinal wound healing; mucosal healing; probiotics.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014. Microbiol Spectr. 2015. PMID: 26185088
-
Probiotics: Shaping the gut immunological responses.World J Gastroenterol. 2024 Apr 21;30(15):2096-2108. doi: 10.3748/wjg.v30.i15.2096. World J Gastroenterol. 2024. PMID: 38681982 Free PMC article. Review.
-
Microbiota and mucosal defense in IBD: an update.Expert Rev Gastroenterol Hepatol. 2019 Oct;13(10):963-976. doi: 10.1080/17474124.2019.1671822. Epub 2019 Oct 11. Expert Rev Gastroenterol Hepatol. 2019. PMID: 31603356 Review.
-
Intestinal microecology-based treatment for inflammatory bowel disease: Progress and prospects.World J Clin Cases. 2023 Jan 6;11(1):47-56. doi: 10.12998/wjcc.v11.i1.47. World J Clin Cases. 2023. PMID: 36687179 Free PMC article. Review.
-
Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut.Mediators Inflamm. 2015;2015:628157. doi: 10.1155/2015/628157. Epub 2015 Oct 25. Mediators Inflamm. 2015. PMID: 26582965 Free PMC article. Review.
Cited by
-
Special Issue "Gut Microbiota, Inflammatory Bowel Diseases, and Therapeutic Targets".Pharmaceuticals (Basel). 2023 May 8;16(5):714. doi: 10.3390/ph16050714. Pharmaceuticals (Basel). 2023. PMID: 37242497 Free PMC article.
-
Lactobacillus rhamnosus modulates murine neonatal gut microbiota and inflammation caused by pathogenic Escherichia coli.BMC Microbiol. 2024 Nov 6;24(1):452. doi: 10.1186/s12866-024-03598-6. BMC Microbiol. 2024. PMID: 39506682 Free PMC article.
-
Christensenella minuta protects and restores intestinal barrier in a colitis mouse model by regulating inflammation.NPJ Biofilms Microbiomes. 2024 Sep 19;10(1):88. doi: 10.1038/s41522-024-00540-6. NPJ Biofilms Microbiomes. 2024. PMID: 39294159 Free PMC article.
-
The Antidiabetic Potential of Probiotics: A Review.Nutrients. 2024 Jul 31;16(15):2494. doi: 10.3390/nu16152494. Nutrients. 2024. PMID: 39125375 Free PMC article. Review.
-
Mucosa and microbiota - the role of intrinsic parameters on intestinal wound healing.Front Surg. 2022 Jul 22;9:905049. doi: 10.3389/fsurg.2022.905049. eCollection 2022. Front Surg. 2022. PMID: 35937599 Free PMC article. Review.
References
-
- Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., Steinhart A.H., Abraham C., Regueiro M., Griffiths A., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006;314:1461–1463. doi: 10.1126/science.1135245. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources